BML Capital Management as of June 30, 2025
Portfolio Holdings for BML Capital Management
BML Capital Management holds 24 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Atea Pharmaceuticals (AVIR) | 20.7 | $27M | 7.6M | 3.60 | |
| Third Harmonic Bio (THRD) | 15.7 | $21M | 3.8M | 5.43 | |
| Aclaris Therapeutics (ACRS) | 15.3 | $20M | 14M | 1.42 | |
| Instil Bio Com New (TIL) | 8.4 | $11M | 535k | 20.83 | |
| Essa Pharma Com New (EPIX) | 5.4 | $7.2M | 4.2M | 1.70 | |
| Oramed Pharmaceuticals Com New (ORMP) | 5.2 | $6.9M | 3.1M | 2.25 | |
| Adverum Biotechnologies Com New (ADVM) | 5.0 | $6.6M | 3.1M | 2.15 | |
| Ikena Oncology (IKNA) | 4.1 | $5.4M | 4.0M | 1.34 | |
| Pmv Pharmaceuticals (PMVP) | 4.0 | $5.3M | 5.0M | 1.06 | |
| Alumis (ALMS) | 2.7 | $3.6M | 1.2M | 3.00 | |
| Kezar Life Sciences Com New (KZR) | 2.2 | $2.9M | 635k | 4.58 | |
| Lava Therapeutics Nv SHS (LVTX) | 2.0 | $2.6M | 2.0M | 1.32 | |
| Milestone Pharmaceuticals (MIST) | 1.7 | $2.2M | 1.1M | 1.94 | |
| Elevation Oncology (ELEV) | 1.6 | $2.2M | 5.9M | 0.37 | |
| Connect Biopharma Hldgs Ads (CNTB) | 1.4 | $1.8M | 1.8M | 0.98 | |
| Tesla Motors Put Option (TSLA) | 1.3 | $1.7M | 200.00 | 8270.00 | |
| Astrotech Corp (ASTC) | 1.0 | $1.3M | 220k | 5.78 | |
| Athira Pharma (ATHA) | 0.7 | $976k | 3.2M | 0.30 | |
| Lisata Therapeutics (LSTA) | 0.5 | $608k | 210k | 2.90 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $475k | 119k | 4.00 | |
| Turnstone Biologics Corp (TSBX) | 0.3 | $396k | 1.1M | 0.36 | |
| Vistagen Therapeutics Ord (VTGN) | 0.2 | $300k | 150k | 2.00 | |
| Hillevax | 0.1 | $183k | 92k | 1.99 | |
| Verrica Pharmaceuticals | 0.1 | $93k | 175k | 0.53 |
